Effect of platelet counts and activator in platelet rich plasma to help in growth of hair in male type baldness

Not Applicable

• Conditions: Health Condition 1: L649- Androgenic alopecia, unspecified

• Registration Number: CTRI/2019/05/019092
• Lead Sponsor: Institute of Medical Science Banaras Hindu University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

Patient of androgenetic alopecia having Halminton norwood scale 2-5

Exclusion Criteria

All the patient using topical minoxidil finasteride and systemic finasteride for at least 3 month

Patient not giving informed consent or unable to understand the protocol and uncooperative patients

any inflammation erythema or scaling over scalp

Patient who have history of malignancies platelet disorders anemia or bleeding disorder bone marrow aplasia uncontrolled diabetes sepsis and cancer

Patient who are known to be HIV hepatitis B or C positive or immunocompromised

Patients who have active skin disease or skin infection at the intended treatment area

Patients with a propensity for keloids

Patients on antiplatelet drug like aspirin or non steroidal anti inflammatory drugs

Patients taking drugs known to cause alopecia like anticoagulants beta blocker ACE inhibitors OCP valproic acid lithium etc

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To evaluate hair counts hair density hair thicknessTimepoint: six months

Secondary Outcome Measures

Name	Time	Method
Subjective assessment using questionaireTimepoint: six months